After crossing the mitochondrial membranes, the majority of mitochondrial precursors require proteolytic processing to become functional. The maturation step removes the mitochondrial targeting signal, the N-terminal presequence, which appr. 70% of all mitochondrial precursor proteins use to direct their import into the organelle. Using global N-proteomic approaches, we identified the substrate spectrum of the main Mitochondrial Processing Protease (MPP) and identified a secondary cleavage event required to stabilize the newly imported proteins. For this quality control, the Intermediate Cleaving Peptidase 55 (Icp55) or the OCTapeptidylaminopeptidase 1 (Oct1) removes a single amino acid or an additional octapeptide. The cleaved presequences and octapeptides are then degraded by the peptidases Cym1, Ste23 and Prd1. Together, these proteases form the presequence processing machinery and ensure proper protein maturation and hence proteome stability.
Dysfunction of presequence proteases causes severe human diseases such as neurodegeneration and cardiomyopathies. While we have a good understanding of the physiological relevance of presequence processing, we now want to understand the consequences of its dysfunction. To this end, we are introducing patient mutations into homologous yeast proteins and human cell lines to analyze the pathophysiological effects of patient mutations in molecular detail.